InvestorsHub Logo
Followers 563
Posts 39671
Boards Moderated 2
Alias Born 06/08/2006

Re: None

Thursday, 10/13/2016 8:22:07 AM

Thursday, October 13, 2016 8:22:07 AM

Post# of 2139
CTEV - CMX157 Demonstrates 99% Viral Load Reduction in Ongoing Head-to-Head Phase 2a Clinical Study Vs. Viread® in Hepatitis B Patients
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEPA News